WO2003087077A1 - A semi-synthetic process for the preparation of n­ debenzoylpaclitaxel - Google Patents

A semi-synthetic process for the preparation of n­ debenzoylpaclitaxel Download PDF

Info

Publication number
WO2003087077A1
WO2003087077A1 PCT/EP2003/003017 EP0303017W WO03087077A1 WO 2003087077 A1 WO2003087077 A1 WO 2003087077A1 EP 0303017 W EP0303017 W EP 0303017W WO 03087077 A1 WO03087077 A1 WO 03087077A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
compound
nitrobenzenesulfenyl
acid
preparation
Prior art date
Application number
PCT/EP2003/003017
Other languages
French (fr)
Inventor
Ezio Bombardelli
Gabriele Fontana
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA2482131A priority Critical patent/CA2482131C/en
Priority to AT03714874T priority patent/ATE314357T1/en
Priority to KR1020047015090A priority patent/KR101159837B1/en
Priority to IL16448603A priority patent/IL164486A0/en
Priority to EP03714874A priority patent/EP1495011B1/en
Priority to SI200330149T priority patent/SI1495011T1/en
Priority to DE60303023T priority patent/DE60303023T2/en
Priority to AU2003219094A priority patent/AU2003219094B2/en
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Priority to JP2003584033A priority patent/JP5197908B2/en
Publication of WO2003087077A1 publication Critical patent/WO2003087077A1/en
Priority to IL164486A priority patent/IL164486A/en
Priority to NO20044291A priority patent/NO328960B1/en
Priority to US10/961,044 priority patent/US7053222B2/en
Priority to HK05107780A priority patent/HK1075661A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the present invention relates to a process for the preparation of N-debenzoylpaclitaxel (I)
  • the derivative of formula (I) is obtained by condensation of an oxazolidine of general formula (II) or of a reactive derivative thereof
  • the present invention is advantageous over the synthetic processes of the prior art, in that: the oxazolidine of general formula (II) is surprisingly enriched in one of the epimers at C 2; all the nitrogen- and oxygen- protecting groups are simultaneously removed by simple solvolysis; the reaction conditions minimize the formation of isomerization or degradation products.
  • Rl is preferably phenyl or phenyl substituted with one or more C C 3 alkoxy, halogen, C C 3 alkyl, halogen- -C ⁇ alkyl groups. More preferably, Rl is 2,4-dimethoxyphenyl.
  • R2 can be any hydroxy-protecting group which can be removed by acid- catalyzed solvolysis.
  • suitable protective groups are acetals (particularly methoxypropyl), alkoxycarbonyls (such as t-butoxycarbonyl), sulfenyl derivatives (such as 2-nitrobenzenesulfenyl). Particularly preferred is the protection with the 2-nitrobenzenesulfenyl group.
  • the baccatin derivative of general formula (III) is esterified with an acid, salt or reactive derivative of general formula (II) in the presence of a condensing agent, for example a carbodiimide such as cyclohexylcarbodiimide or l-(3-dimethylaminopropyl)-3- ethylcarbodiimide and an activating agent such as 4-dimethylaminopyridine or N-methylimidazole, in organic solvents selected from ethers (particularly tetrahydrofuran), hydrocarbons (such as toluene or hexane), halogenated hydrocarbons (particularly dichloromethane), or mixtures thereof at temperatures ranging from 0 to 90°C. It is particularly advantageous to carry out the reaction in toluene and dichloromethane at a temperature of about 70°C.
  • a condensing agent for example a carbodiimide such as cyclohexylcarbodiimide or
  • Rl is as defined above and R3, R4 and R5, which can be the same or different, are a C C 6 alkyl group, in particular ethyl, aryl or arylalkyl, preferably benzyl.
  • R3, R4 and R5, which can be the same or different, are a C C 6 alkyl group, in particular ethyl, aryl or arylalkyl, preferably benzyl.
  • any activated carboxylic acid derivative (III), such as mixed anhydrides, acyl halides, pentafluorophenyl ester, thioesters, can be used in the process of the invention according to known procedures.
  • the oxygen- and nitrogen-protecting groups are removed in a single step by acid-catalyzed solvolysis, preferably by treatment with methanol and p-toluenesulfonic acid, at a temperature ranging from -20 to 50°C.
  • the acid of formula (II) can be obtained by hydrolysis of an ester of formula (NI)
  • the hydrolysis is usually carried out in alkali medium by means of inorganic bases, such as metal hydroxides or metal carbonates, in a water-alcoholic medium at a temperature ranging from 0 to 40°C.
  • inorganic bases such as metal hydroxides or metal carbonates
  • ester (VI) in which Rl is 2,4-dimethoxyphenyl can be obtained by reacting 2,4-dimethoxybenzaldehyde dimethylacetal (X) with N-(2-nitrobenzenesulfenyl)-3-phenylisoserine of formula (IX)
  • Suitable solvents are aromatic hydrocarbons.
  • the compound of formula (IX) can be prepared by reacting 3-phenylisoserine hydrochloride methyl ester with 2-nitrobenzenesulfenyl chloride in a diphasic mixture consisting of a water- immiscibile inert organic solvent (preferably ethyl acetate or dichloromethane) and an aqueous basic buffer (such as a sodium bicarbonate saturated solution) at temperatures ranging from 4 to 50°C.
  • a water- immiscibile inert organic solvent preferably ethyl acetate or dichloromethane
  • an aqueous basic buffer such as a sodium bicarbonate saturated solution
  • 7-(2-Nitrobenzenesulfenyl)-baccatin III can be easily prepared by reacting baccatin III with 2-nitrobenzenesulfenyl chloride in inert solvents, particularly ethers or halogenated hydrocarbons, in the presence of an organic or inorganic base, at temperatures ranging from -10 to 40°C.
  • inert solvents particularly ethers or halogenated hydrocarbons
  • Example I N-(2-nitrobenzenesuIfenyl)-3-phenylisoserine.
  • Example II 2-(2,4-dimethoxyphenyl)-3-(2-nitrobenzenesulfenyl)-4- phenyl-5-oxazolidinecarboxylic acid methyl ester.
  • Example III sodium 2-(2,4-dimethoxyphenyl)-3-(2-nitrobenzene- sulfenyD-4-phenyl-5-oxazolidinecarboxylate.
  • Example IV triethylammonium 2-(2,4-dimethoxyphenyD-3-(2- nitrobenzenesulfenyl)-4-phenyl-5-oxazolidinecarboxylate.
  • Example VI 13-[N-(2-nitrobenzenesulfenyl)-N,Q-(2,4-dimethoxy- benzylidene -3-phenylisoserinoyn-7-(2-nitrobenzenesulfenyl)-baccatin III

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A process for the preparation of N-debenzoylpaclitaxel (I) through esterification of 7-protected baccatin III with a carboxylic acid reactive derivative of general formula (II), and elimination of the ester-protecting groups in acid conditions and in a single step. In formula (II) R1 is aryl or heteroaryl. The compound of formula (I) can be conveniently used for the preparation of paclitaxel and analogues.

Description

A SEMI-SYNTHETIC PROCESS FOR THE PREPARATION OF N- DEBENZOYLPACLITAXEL
Disclosure of the invention
' The present invention relates to a process for the preparation of N-debenzoylpaclitaxel (I)
Figure imgf000002_0001
which is a useful precursor for known molecules having antitumor activity.
According to present invention, the derivative of formula (I) is obtained by condensation of an oxazolidine of general formula (II) or of a reactive derivative thereof
Figure imgf000002_0002
(ID in which Rl is an aryl or heteroaryl group, with a baccatin derivative of general formula (III)
Figure imgf000002_0003
in which R2 is a hydroxy-protecting group removable by acid-catalyzed solvolysis, to give a compound of general formula (IV)
Figure imgf000003_0001
in which Rl and R2 are as defined above, which compound is subjected to controlled acidic conditions to afford in a single step the compound of formula (I), an useful intermediate for the preparation of known antitumor compounds.
The present invention is advantageous over the synthetic processes of the prior art, in that: the oxazolidine of general formula (II) is surprisingly enriched in one of the epimers at C 2; all the nitrogen- and oxygen- protecting groups are simultaneously removed by simple solvolysis; the reaction conditions minimize the formation of isomerization or degradation products. Rl is preferably phenyl or phenyl substituted with one or more C C3 alkoxy, halogen, C C3 alkyl, halogen- -C^ alkyl groups. More preferably, Rl is 2,4-dimethoxyphenyl.
R2 can be any hydroxy-protecting group which can be removed by acid- catalyzed solvolysis. Examples of suitable protective groups are acetals (particularly methoxypropyl), alkoxycarbonyls (such as t-butoxycarbonyl), sulfenyl derivatives (such as 2-nitrobenzenesulfenyl). Particularly preferred is the protection with the 2-nitrobenzenesulfenyl group. According to present invention, the baccatin derivative of general formula (III) is esterified with an acid, salt or reactive derivative of general formula (II) in the presence of a condensing agent, for example a carbodiimide such as cyclohexylcarbodiimide or l-(3-dimethylaminopropyl)-3- ethylcarbodiimide and an activating agent such as 4-dimethylaminopyridine or N-methylimidazole, in organic solvents selected from ethers (particularly tetrahydrofuran), hydrocarbons (such as toluene or hexane), halogenated hydrocarbons (particularly dichloromethane), or mixtures thereof at temperatures ranging from 0 to 90°C. It is particularly advantageous to carry out the reaction in toluene and dichloromethane at a temperature of about 70°C.
Among the acid derivatives of formula (II), particularly preferred is the use of an ammonium salt of formula (V)
Figure imgf000004_0001
wherein Rl is as defined above and R3, R4 and R5, which can be the same or different, are a C C6 alkyl group, in particular ethyl, aryl or arylalkyl, preferably benzyl. The use of the ammonium salt provides less drastic reaction conditions and better stability of the products involved.
In principle, any activated carboxylic acid derivative (III), such as mixed anhydrides, acyl halides, pentafluorophenyl ester, thioesters, can be used in the process of the invention according to known procedures.
The oxygen- and nitrogen-protecting groups are removed in a single step by acid-catalyzed solvolysis, preferably by treatment with methanol and p-toluenesulfonic acid, at a temperature ranging from -20 to 50°C. The acid of formula (II) can be obtained by hydrolysis of an ester of formula (NI)
Figure imgf000005_0001
(VI) to give a salt of formula (Nil)
Figure imgf000005_0002
(VII) wherein M is a metal having y charge ranging from 1 to 2 and n is an integer always equal to y.
The hydrolysis is usually carried out in alkali medium by means of inorganic bases, such as metal hydroxides or metal carbonates, in a water-alcoholic medium at a temperature ranging from 0 to 40°C.
The triethylammonium salts of formula (VIII)
Figure imgf000005_0003
can be obtained by treating the salts of formula (VII) with a triethylammonium chloride methanolic solution in a wide range of temperatures.
The ester (VI) in which Rl is 2,4-dimethoxyphenyl can be obtained by reacting 2,4-dimethoxybenzaldehyde dimethylacetal (X) with N-(2-nitrobenzenesulfenyl)-3-phenylisoserine of formula (IX)
Figure imgf000006_0001
in an inert organic solvent, or in mixtures of inert organic solvents, in the presence of a mild acid catalyst such as pyridinium p-toluenesulfonate at a temperature ranging from 0°C to the boiling temperature of the mixture. Suitable solvents are aromatic hydrocarbons.
The compound of formula (IX) can be prepared by reacting 3-phenylisoserine hydrochloride methyl ester with 2-nitrobenzenesulfenyl chloride in a diphasic mixture consisting of a water- immiscibile inert organic solvent (preferably ethyl acetate or dichloromethane) and an aqueous basic buffer (such as a sodium bicarbonate saturated solution) at temperatures ranging from 4 to 50°C.
7-(2-Nitrobenzenesulfenyl)-baccatin III can be easily prepared by reacting baccatin III with 2-nitrobenzenesulfenyl chloride in inert solvents, particularly ethers or halogenated hydrocarbons, in the presence of an organic or inorganic base, at temperatures ranging from -10 to 40°C. The compounds:
7-(2-nitrobenzenesulfenyl)-baccatin III;
13-[N-(2-nitrobenzenesulfenyl)-N,0-(2,4-dimethoxybenzylidene)-3- phenylisoserinoyl]-7-(2-nitrobenzenesulfenyl)-baccatin III; 2-(2,4-dimethoxyphenyl)-3-(2-nitrobenzenesulfenyl)-4-phenyl-5-oxazo- lidinecarboxylic acid and the salts and C1-C3 alkyl esters thereof, in particular the sodium and triethylammonium salts and the methyl ester; N-(2-nitrobenzenesulfenyl)-3-phenylisoserine, are novel, useful intermediates and are a further object of the invention.
The following examples illustrate the invention in greater detail.
Examples
Example I: N-(2-nitrobenzenesuIfenyl)-3-phenylisoserine.
5 g of phenylisoserine methyl ester dissolved in 100 ml of ethyl acetate and 130 ml of a saturated NaHC03 solution are mixed in a 500-ml round- bottom flask. The diphasic mixture is kept under vigorous stirring and 5 g of 2-nitrobenzenesulfenyl chloride are added thereto in 30 minutes. The mixture is left under stirring for 30 min, then the organic phase is separated, dried over sodium sulfate and evaporated under reduced pressure. The residual yellow oil is purified by chromatography (silica,hexane - ethyl acetate, gradient 25 to 50% ethyl acetate) to give the desired product in 74% yield.
Example II: 2-(2,4-dimethoxyphenyl)-3-(2-nitrobenzenesulfenyl)-4- phenyl-5-oxazolidinecarboxylic acid methyl ester.
A hot solution of 6.6 g N-(2-nitrobenzenesulfenyl)-3 -phenylisoserine in 100 ml of dry benzene is added with 0.5 g of pyridinium p-toluenesulfonate and 5.3 g of 2,4-dimethoxybenzaldehyde dimethylacetal. The solution is refluxed for 4 hours, then left to cool to room temperature. After that, 10 ml of a NaHC03 saturated solution are added and the phases are separated. The aqueous phase is extracted with ethyl acetate and the combined organic phases are dried over Na2S04 and evaporated under reduced pressure. The residual yellow oil is purified by chromatography (silica,hexane-ethyl acetate 5: 1 with 2% triethylamine) to give the desired product in 74% yield.
Example III: sodium 2-(2,4-dimethoxyphenyl)-3-(2-nitrobenzene- sulfenyD-4-phenyl-5-oxazolidinecarboxylate.
A solution of 5 g of 2-(2,4-dimethoxyphenyl)-3-(2- nitrobenzenesulfenyl)-4-phenyl-5-oxazolidinecarboxylic acid methyl ester in 150 ml of methanol are added with 22 ml of 2% sodium hydroxide. The mixture is refluxed for 1 hour. The solvent is distilled off and the residue is dried at 40°C under vacuum overnight.
Example IV: triethylammonium 2-(2,4-dimethoxyphenyD-3-(2- nitrobenzenesulfenyl)-4-phenyl-5-oxazolidinecarboxylate.
A solution of 13 mmol of the salt described above in 20 ml of dry methanol is added with 1.83 g of triethylammonium chloride. The mixture is kept under stirring for 3 hours, then diluted with 150 ml of toluene. The resulting suspension is filtered with suction and the mother liquors are evaporated to give the desired product in almost quantitative yield. The product is used without further purification.
Example V: 7-(2-nitrobenzenesulfenyl)-baccatin HI
8.8 g of baccatin III and 3.13 g of 2-nitrobenzenesulfenyl chloride are dissolved in 100 ml of dry methylene chloride in a 500-ml round-bottom flask. After cooling the solution at 0°C, 5 ml of pyridine are dropped therein at such a rate as to keep temperature below 5°C. The mixture is then kept under stirring at 0°C for 30 min, then diluted with 50 ml of methylene chloride and washed with 5% NaHC03 and then with brine. After drying over magnesium sulfate, the organic phase is evaporated under reduced pressure. The resulting crude is purified by chromatography (silica,hexane - ethyl acetate 6:4) to give 5.4 g of the desired product.
Example VI: 13-[N-(2-nitrobenzenesulfenyl)-N,Q-(2,4-dimethoxy- benzylidene -3-phenylisoserinoyn-7-(2-nitrobenzenesulfenyl)-baccatin III
A mixture of 2.9 g of 7-(2-nitrobenzenesulfenyl)-baccatin III, 2.9 g of triethylammonium 2-(2,4-dimethoxyphenyl)-3-(2-nitrobenzenesulfenyl)-4- phenyl-5-oxazolidinecarboxylate in 15 ml of methylene chloride and 30 ml of dry toluene, is added with 1.5 g of dicyclohexylcarbodiimide and 0.24 g of 4- dimethylaminopyridine. The reaction mixture is refluxed for 2 hours, then left under stirring at room temperature overnight. The organic phase is filtered with suction, then washed with 30 ml of saturated sodium hydrogen carbonate, then with brine and evaporated under reduced pressure. The residue is purified by chromatography (silica,hexane-ethyl acetate 7:3) to give the desired product in 75% yield.
Example VII: N-debenzoylpaclitaxel.
4.4 g of 13-[N-(2-nitrobenzenesulfenyl)-N,0-(2,4- dimethoxybenzylidene)-3-phenylisoserinoyl]-7-(2-nitrobenzenesulfenyl)- baccatin III and 1.4 g of p-toluenesulfonic acid are dissolved in 15 ml of dry methanol at 0°C. The solution is left under stirring at 0°C for 3-8 hours. The reaction is monitored by TLC. 15 ml of a sodium bicarbonate saturated solution are then added, the solvent is evaporated off and the residue is dissolved in ethyl acetate. The organic layer is washed with water and dried over Na2S0 . Evaporation of the solvent and purification on a column (methylene chloride - methanol 95:5) give the desired product in 80% yield.

Claims

1. A process for the preparation of N-debenzoylpaclitaxel (I)
Figure imgf000010_0001
which comprises:
(a) condensing a carboxylic acid of general formula (II), or a salt or an activated derivative thereof
Figure imgf000010_0002
(II) in which Rl is an aryl or heteroaryl group, with a baccatin derivative of general formula (III)
Figure imgf000010_0003
(i l l) in which R2 is a hydroxy-protecting group removable by acid-catalyzed solvolysis, to give a compound of formula (IV)
Figure imgf000011_0001
in which Rl and R2 are as defined above; b) removing the R2 group and opening the oxazolidine ring in the compound of formula (IV) by acid-catalyzed solvolysis.
2. A process as claimed in claim 1 wherein Rl is 2,4-dimethoxyphenyl and R2 is 2-nitrobenzenesulfenyl.
3. A process as claimed in claim 1 or 2 in which step a) is carried out in the presence of a condensing agent and of an activating agent in organic solvents selected from ethers, hydrocarbons, halogenated hydrocarbons, or mixtures thereof at temperatures ranging from 0 to 90°C.
4. A process as claimed in claim 3 in which the solvent is a mixture of toluene and dichloromethane and the reaction temperature is approx. 70°C.
5. A process as claimed in any one of claims 1 to 4 in which compound (III) is reacted with an ammonium salt of formula (V)
Figure imgf000011_0002
wherein Rl is as defined above and R3, R4 and R5 are a C1-C6 alkyl, aryl or arylalkyl group.
6. A process as claimed in any one of claims 1 to 5 in which the oxygen- and nitrogen- protecting groups are removed in a single step by treatment with methanol and p-toluenesulfonic acid, at a temperature ranging from -20 to 50°C.
7. A process for the preparation of the compounds of formula (II) which comprises: a) preparation of the N-(2-nitrobenzenesulfenyl)-3-phenylisoserine methyl ester of formula (IX);
Figure imgf000012_0001
b) treatment of compound (IX) with an aldehyde dimethylacetal to give a compound of formula (VI)
Figure imgf000012_0002
in which Rl is defined as above; c) hydrolysis of the ester of formula (VI) to give a salt of formula (VII)
Figure imgf000012_0003
(VII) wherein Rl is as defined in claim 1, M is a metal with y positive charge ranging from 1 to 2, and n is an integer which is always equal to y; d) acidification of the salt of formula (VII) to give the compound of formula (II).
8. A process as claimed in claim 7 in which the hydrolysis is carried out in alkali medium by means of metal hydroxides or metal carbonates in a water- alcoholic medium at a temperature ranging from 0 to 40°C.
9. A process as claimed in claim 7 in which step b) is carried out by heating compound (IX) with 2,4-dimethoxybenzaldehyde dimethylacetal in an inert organic solvent, or in mixtures of inert organic solvents, in the presence of a mild acid catalyst, at a temperature ranging from 0°C to the boiling temperature of the mixture.
10. A process for the preparation of a compound of formula (V) in which R3, R4 and R5 are ethyl, by treatment of a compound of formula (VII) as defined in claim 7, in which M is preferably sodium, with a triethylammonium chloride methanolic solution.
11. A compound selected from: 7-(2-nitrobenzenesulfenyl)-baccatin III;
13-[N-(2-nitrobenzenesulfenyl)-N,0-(2,4-dimethoxybenzylidene)-3- phenylisoserinoyl]-7-(2-nitrobenzenesulfenyl)-baccatin III; 2-(2,4-dimethoxyphenyl)-3-(2-nitrobenzenesulfenyl)-4-phenyl-5-oxazo- lidinecarboxylic acid and the salts and C1-C3 alkyl esters thereof, in particular the sodium and triethylammonium salts and the methyl ester; N-(2-nitrobenzenesulfenyl)-3-phenylisoserine.
PCT/EP2003/003017 2002-04-12 2003-03-24 A semi-synthetic process for the preparation of n­ debenzoylpaclitaxel WO2003087077A1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
DE60303023T DE60303023T2 (en) 2002-04-12 2003-03-24 HALF-SYNTHETIC METHOD FOR THE PREPARATION OF N-DEBENZOYLPACLITAXEL
KR1020047015090A KR101159837B1 (en) 2002-04-12 2003-03-24 A semi-synthetic process for the preparation of N-debenzoylpaclitaxel
IL16448603A IL164486A0 (en) 2002-04-12 2003-03-24 A semi-synthetic process for the preparation of n-debenzoylpaclitaxel
EP03714874A EP1495011B1 (en) 2002-04-12 2003-03-24 A semi-synthetic process for the preparation of n debenzoylpaclitaxel
SI200330149T SI1495011T1 (en) 2002-04-12 2003-03-24 A semi-synthetic process for the preparation of n debenzoylpaclitaxel
CA2482131A CA2482131C (en) 2002-04-12 2003-03-24 A semi-synthetic process for the preparation of n­debenzoylpaclitaxel
AU2003219094A AU2003219094B2 (en) 2002-04-12 2003-03-24 A semi-synthetic process for the preparation of N debenzoylpaclitaxel
AT03714874T ATE314357T1 (en) 2002-04-12 2003-03-24 SEMI-SYNTHETIC PROCESS FOR THE PRODUCTION OF N-DEBENZOYLPACLITAXEL
JP2003584033A JP5197908B2 (en) 2002-04-12 2003-03-24 Semi-synthetic method for the preparation of N-debenzoyl paclitaxel
IL164486A IL164486A (en) 2002-04-12 2004-10-11 Semi-synthetic process for the preparation of n-debenzoylpaclitaxel
NO20044291A NO328960B1 (en) 2002-04-12 2004-10-11 Process of semi-synthetic preparation of N-debenzoyl paclitaxel
US10/961,044 US7053222B2 (en) 2002-04-12 2004-10-12 Semi-synthetic process for the preparation of N-debenzoylpaclitaxel
HK05107780A HK1075661A1 (en) 2002-04-12 2005-09-05 A semi-synthetic process for the preparation of n debenzoylpaclitavel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000782A ITMI20020782A1 (en) 2002-04-12 2002-04-12 SEMI-SYNTHETIC PROCESS FOR THE PREPARATION OF N-DEBENZOILPACLITAXEL
ITMI2002A000782 2002-04-12

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/961,044 Continuation-In-Part US7053222B2 (en) 2002-04-12 2004-10-12 Semi-synthetic process for the preparation of N-debenzoylpaclitaxel

Publications (1)

Publication Number Publication Date
WO2003087077A1 true WO2003087077A1 (en) 2003-10-23

Family

ID=11449694

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/003017 WO2003087077A1 (en) 2002-04-12 2003-03-24 A semi-synthetic process for the preparation of n­ debenzoylpaclitaxel

Country Status (18)

Country Link
US (1) US7053222B2 (en)
EP (1) EP1495011B1 (en)
JP (2) JP5197908B2 (en)
KR (2) KR20100036394A (en)
CN (1) CN1310897C (en)
AT (1) ATE314357T1 (en)
AU (1) AU2003219094B2 (en)
CA (1) CA2482131C (en)
DE (1) DE60303023T2 (en)
DK (1) DK1495011T3 (en)
ES (1) ES2254921T3 (en)
HK (1) HK1075661A1 (en)
IL (2) IL164486A0 (en)
IT (1) ITMI20020782A1 (en)
NO (1) NO328960B1 (en)
PL (1) PL209650B1 (en)
RU (1) RU2302415C2 (en)
WO (1) WO2003087077A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2161260A1 (en) 2004-10-08 2010-03-10 INDENA S.p.A. Semisynthesis process for the preparation of 10 deacetyl-n-debenzoyl-paclitaxel

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020782A1 (en) * 2002-04-12 2003-10-13 Indena Spa SEMI-SYNTHETIC PROCESS FOR THE PREPARATION OF N-DEBENZOILPACLITAXEL
ITMI20050614A1 (en) * 2005-04-12 2006-10-13 Indena Spa PROCESS FOR THE PURIFICATION OF 10-DEACETYLBACCHATIN III FROM 10-DEACETIL-2-DEBENZOYL-2-PENTENOYLABACCATIN III
WO2008074178A1 (en) * 2006-11-23 2008-06-26 Shanghai Bailing Pharmaceutical Technology Co., Ltd A new semisynthetic process of pacutaxel

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997042167A1 (en) * 1996-05-08 1997-11-13 Pharmacia & Upjohn Company Process to prepare taxol
WO1998008833A1 (en) * 1996-08-26 1998-03-05 Bristol-Myers Squibb Company Sulfenamide taxane derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2155304C (en) * 1993-02-05 2010-07-20 Charles Swindell Syntheses of paclitaxel, analogs and intermediates with variable a-ring side chains
US5917062A (en) * 1997-11-21 1999-06-29 Indena S.P.A Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
ITMI20020782A1 (en) * 2002-04-12 2003-10-13 Indena Spa SEMI-SYNTHETIC PROCESS FOR THE PREPARATION OF N-DEBENZOILPACLITAXEL

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997042167A1 (en) * 1996-05-08 1997-11-13 Pharmacia & Upjohn Company Process to prepare taxol
WO1998008833A1 (en) * 1996-08-26 1998-03-05 Bristol-Myers Squibb Company Sulfenamide taxane derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2161260A1 (en) 2004-10-08 2010-03-10 INDENA S.p.A. Semisynthesis process for the preparation of 10 deacetyl-n-debenzoyl-paclitaxel

Also Published As

Publication number Publication date
US20050049297A1 (en) 2005-03-03
KR20040105795A (en) 2004-12-16
NO328960B1 (en) 2010-06-28
PL209650B1 (en) 2011-09-30
EP1495011B1 (en) 2005-12-28
KR20100036394A (en) 2010-04-07
CN1310897C (en) 2007-04-18
NO20044291L (en) 2004-10-11
CA2482131C (en) 2012-07-17
RU2302415C2 (en) 2007-07-10
ES2254921T3 (en) 2006-06-16
DE60303023T2 (en) 2006-09-28
KR101159837B1 (en) 2012-06-25
JP5197908B2 (en) 2013-05-15
IL164486A (en) 2008-11-26
JP2005530729A (en) 2005-10-13
ITMI20020782A1 (en) 2003-10-13
CN1646512A (en) 2005-07-27
PL371673A1 (en) 2005-06-27
AU2003219094A1 (en) 2003-10-27
IL164486A0 (en) 2005-12-18
US7053222B2 (en) 2006-05-30
AU2003219094B2 (en) 2008-06-26
ITMI20020782A0 (en) 2002-04-12
JP2010265274A (en) 2010-11-25
DK1495011T3 (en) 2006-05-15
DE60303023D1 (en) 2006-02-02
EP1495011A1 (en) 2005-01-12
HK1075661A1 (en) 2005-12-23
CA2482131A1 (en) 2003-10-23
ATE314357T1 (en) 2006-01-15
RU2004130316A (en) 2005-06-27

Similar Documents

Publication Publication Date Title
EP0982302B1 (en) Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
KR100311198B1 (en) Manufacturing method of taxane derivative
US5637723A (en) Process for preparing taxane derivatives
US5977375A (en) Esters of baccatin III and 10-deacetylbaccatin III
US5621121A (en) Process for the preparation of taxane derivatives
JP4971169B2 (en) Semi-synthetic method for the preparation of 10-deacetyl-N-debenzoyl paclitaxel
US5686623A (en) Method for preparing taxane derivatives
KR100660663B1 (en) A Process for the Preparation of Taxanes from 10-Deacetylbaccatin III
JP2010265274A (en) Semi-synthetic method for production of n-debenzoylpaclitaxel
AU712898B2 (en) Method for the preparation of taxol and its derivatives
IL121599A (en) Process for preparing paclitaxel
EP1575929B1 (en) The method for production of semi-finished products useful in synthesis of paclitaxel
HU221164B1 (en) Method for the preparation of 1,3-oxazolidin 5-carboxylic acid
EP1647552A1 (en) Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1020047015090

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 3077/DELNP/2004

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2482131

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2004130316

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2003219094

Country of ref document: AU

Ref document number: 20038081881

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2003584033

Country of ref document: JP

Ref document number: 10961044

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2003714874

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020047015090

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003714874

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2003714874

Country of ref document: EP